The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.10.1002/ijc.25516Search in Google Scholar

2. Cancer in Slovenia 2009. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia. 2013 [citated 2013 Nov 25]. Available from: http://www.onko-i.si/eng/crs.Search in Google Scholar

3. Tepeš B, Kavalar R. [Gastric cancer, screening possibilities and proposals for endoscopic and histologic follow-up of premalignant gastric lesions]. [Slovenian]. Zdrav Vestn 2010; 79: 366-74.Search in Google Scholar

4. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 2008; 44: 2397-403.10.1016/j.ejca.2008.07.031Search in Google Scholar

5. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-90.10.1128/CMR.00054-05Search in Google Scholar

6. Kodama M, Murakami K, Sato R, Okimoto T, Nishizono A, Fujioka T. Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis. World J Gastroenterol 2005; 11: 7063-71.10.3748/wjg.v11.i45.7063Search in Google Scholar

7. Manxhuka-Kerliu S, Telaku S, Devolli-Disha E, Ahmetaj H, Sahatciu-Meka V, Kerliu A, et al. 2009. Helicobacter pylori gastritis updated Sydney classification applied in our material. Prilozi 2009; 30: 45-60.Search in Google Scholar

8. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004; 173: 1406-16.10.4049/jimmunol.173.2.1406Search in Google Scholar

9. Lu W, Pan H, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of inter-leukin IL-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-6.10.1093/carcin/bgh349Search in Google Scholar

10. Correa P, Haensze, W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.10.1016/S0140-6736(75)90498-5Search in Google Scholar

11. Jorge YC, Duarte MC, Silva AE. Gastric cancer is associated with NOS2-954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol 2010; 10: 64-84.10.1186/1471-230X-10-64290641120565800Search in Google Scholar

12. Murphy G, Thornton J, McManus R, Swan N, Ryan B, O’Morain CA, et al. Association of gastric disease with polymorphisms in the inflammatory related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol 2009; 21: 630-5.10.1097/MEG.0b013e3283140eea280281619295440Search in Google Scholar

13. Melo Barbosa HP, Martins LC, Dos Santos SE, Demachki S, Assumpção MB, Aragão CD, et al. Interleukin-1 and TNF-α polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol 2009; 15: 1465-71.10.3748/wjg.15.1465266514019322919Search in Google Scholar

14. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17: 117-25.10.1007/s10552-005-0439-7Search in Google Scholar

15. Moorchung N, Srivastava AN, Gupta NK, Ghoshal UC, Achyut BR, Mittal B. 2007. Cytokine gene polymorphisms and the pathology of chronic gastritis. Singapore Med J 2007; 48: 447-54.Search in Google Scholar

16. Skvarc M, Stubljar D, Kopitar AN, Jeverica S, Tepes B, Kos J, et al. Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori. Radiol Oncol 2013; 47: 258-65.10.2478/raon-2013-0043Search in Google Scholar

17. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T, Yamamoto T, et al. Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 2007; 18: 473-81.Search in Google Scholar

18. Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1B and interleukin-1 RN polymorphism and gastric carcinoma risk: A meta-analysis. J Gastroenterol Hepatol 2010; 25: 1604-17.10.1111/j.1440-1746.2010.06428.xSearch in Google Scholar

19. Sitarz R, de Leng WWJ, Polak M, Morsink FHM, Bakker O, Polkowski WP, et al. IL-1B −31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers. Virchows Arch 2008; 453: 249-55.10.1007/s00428-008-0642-5Search in Google Scholar

20. El-Omar EM, Carrington M, Chow WH, McColl KEL, Breamk JH, Young H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.10.1038/35006081Search in Google Scholar

21. Cauci S, Santolo MD, Ryckman KK, Williams SM, Banfi G. Variable number of tandem repeat polymorphism of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status. BMC Med Genet 2010; 11: 29-40.10.1186/1471-2350-11-29Search in Google Scholar

22. Crusius JB, Canzian F, Capellá G, Peña AS, Pera G, Sala N, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 2008; 19: 1894-902.10.1093/annonc/mdn400Search in Google Scholar

23. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29: 141-52.10.1016/j.cyto.2004.10.013Search in Google Scholar

24. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007; 28: 118-23.10.1093/carcin/bgl130Search in Google Scholar

25. El-Omar EM, Rabkin CS, Marilie DG, Vaughan TL, Harvey AR, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-201.10.1016/S0016-5085(03)00157-4Search in Google Scholar

26. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-71.10.1016/S0016-5085(03)00899-0Search in Google Scholar

27. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-12.10.1053/j.gastro.2006.12.02617324405Search in Google Scholar

28. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the toll-like receptor Asp299Gly, Thr399Ile and interleukin-8 -25 I polymoprhisms in the risk for the development of distal gastric cancer. BMC Cancer 2007; 7: 70.10.1186/1471-2407-7-70186803317462092Search in Google Scholar

29. Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, et al. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobater 2009; 14: 47-53.10.1111/j.1523-5378.2009.00659.x19191896Search in Google Scholar

30. Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 2007; 68: 901-7.10.1016/j.humimm.2007.10.00618082569Search in Google Scholar

31. El-Omar EM, Ng MT, Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 2008; 27: 244-52.10.1038/sj.onc.121091218176606Search in Google Scholar

32. Dixon MF, Genta R, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.10.1097/00000478-199610000-000018827022Search in Google Scholar

33. Szeto ML, Lee CK, Yee YK, Li K., Lee WK, Lee CC, et al. Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2001; 15: 703-6.10.1046/j.1365-2036.2001.00961.x11328265Search in Google Scholar

34. Kirchgesser M, Adem C, Baumgartner A, Girgnhuber H, Malmberg W, Schmitt I, et al. Automated isolation of DNA from tissue samples in 35-50 minutes: Fast and easy purification combining the MagNA Lyser and the MagNA Pure Compact System. Biochemica 2006; 1: 9-10.Search in Google Scholar

35. Highet AR, Gibson CS, Goldwater PN. Variant interleukin 1 receptor antagonist gene alleles in sudden infant death syndrome. Arch Dis Child 2010; 95: 1009-12.10.1136/adc.2010.18826820880945Search in Google Scholar

36. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of rastric carcinoma. Gastroenterology 2001; 121: 823-9.10.1053/gast.2001.2800011606496Search in Google Scholar

37. Kutikhin AG. Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol 2011; 72: 193-206.10.1016/j.humimm.2010.11.00321081146Search in Google Scholar

38. Queiroz DM, Guerra JB, Rocha GA, Rocha AM, Santos A, De Oliveira AG, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004; 127: 73-9.10.1053/j.gastro.2004.03.06915236174Search in Google Scholar

39. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP, et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 2004; 110: 695-700.10.1002/ijc.2019915146559Search in Google Scholar

40. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114: 237-41.10.1002/ijc.2071815540224Search in Google Scholar

41. Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci 2008; 53: 622-9.10.1007/s10620-007-9925-y17717744Search in Google Scholar

42. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promotor polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-6.10.1136/jcp.54.9.703173151611533078Search in Google Scholar

43. Tseng FC, Brown EE, Maiese EM, Yeager M, Welch R, Gold BD, et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 2006; 11: 425-30.10.1111/j.1523-5378.2006.00433.x16961803Search in Google Scholar

44. Chakravorty M, Datta De D, Choulhury A, Santra A, Roychoudhury S. Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population. J Genet 2008; 87: 299-304.10.1007/s12041-008-0048-919147919Search in Google Scholar

45. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006; 55: 158-64.10.1136/gut.2005.072942185648916120761Search in Google Scholar

46. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Instit 2002; 94: 1680-7.10.1093/jnci/94.22.168012441323Search in Google Scholar